Technology News and Research

RSS
StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces investment report featuring GenVec

NDSsi launches ZeroWire Full HD video solution for minimally-invasive surgery

NDSsi launches ZeroWire Full HD video solution for minimally-invasive surgery

A.P. Pharma reports net loss of $1.9M for fourth-quarter of 2009

A.P. Pharma reports net loss of $1.9M for fourth-quarter of 2009

Bone implants that support and release chemotherapeutical agents in ciclodextrin nanocapsule

Bone implants that support and release chemotherapeutical agents in ciclodextrin nanocapsule

GE Healthcare's MAC 800 ECG device to aid medical support at Vancouver 2010 Paralymipc Winter Games

GE Healthcare's MAC 800 ECG device to aid medical support at Vancouver 2010 Paralymipc Winter Games

New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

New trial comparing drug-eluting stents to bypass graft surgery in left main coronary artery disease patients

Specialists convene to address future climatic trends

Specialists convene to address future climatic trends

Clinical trial results from MASCOT Trial evaluating AngioSculpt PTA Scoring Balloon Catheter announced

Clinical trial results from MASCOT Trial evaluating AngioSculpt PTA Scoring Balloon Catheter announced

Study: Chromosomal microarray analysis detects genetic changes related to ASDs better than standard tests

Study: Chromosomal microarray analysis detects genetic changes related to ASDs better than standard tests

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

New PEGylated Polylysine dendrimers: Benefits patients with cancer, HIV and lymphatic conditions

Medafor, Magle Life Sciences of Sweden sign long-term raw material supply agreement

Medafor, Magle Life Sciences of Sweden sign long-term raw material supply agreement

Bio-Path Holdings' liposomal Grb-2 IND receives FDA clearance to proceed into clinical trials

Bio-Path Holdings' liposomal Grb-2 IND receives FDA clearance to proceed into clinical trials

Brain Science Institute, Eisai sign licensing agreement to develop GCPII inhibitors

Brain Science Institute, Eisai sign licensing agreement to develop GCPII inhibitors

Zimmer Holdings showcases Continuum Acetabular Cup System at AAOS 2010

Zimmer Holdings showcases Continuum Acetabular Cup System at AAOS 2010

Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010

Royal Philips Electronics, ACC to present Hybrid OR Suite designed for cardiac procedures at ACC 2010

ampliPHOX detection technology of InDevR in beta site-testing in anticipation of upcoming product launch

ampliPHOX detection technology of InDevR in beta site-testing in anticipation of upcoming product launch

Eisai, Johns Hopkins University's BSI enter into licensing agreement for GCPII technology

Eisai, Johns Hopkins University's BSI enter into licensing agreement for GCPII technology

Experts: Americans get too many tests, too much treatment

Experts: Americans get too many tests, too much treatment

Life insurance industry is for faster pace of change in the use of technology

Life insurance industry is for faster pace of change in the use of technology

St. Jude Medical to exhibit cardiac clinical solution products portfolio at ACC 2010

St. Jude Medical to exhibit cardiac clinical solution products portfolio at ACC 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.